Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
24m agoLinkhome Holdings Inc. Signs MOU to Acquire Mortgage One Group, Accelerating Nationwide Expansion of AI Real Estate & Fintech Platform
25m agoDeluxe and MRI Software Partner to Enhance Payment Capabilities for Property Management Companies
26m agoBox Launches Box Automate to Orchestrate Agentic Workflows
41m agoSCOR SE Combined Shareholders’ Meeting held on Tuesday 28 April 2026 - Approval of all resolutions by SCOR SE shareholders
59m agoROHM Launches an Ultra-Compact Wireless Power Chipset for Wearables
Kala Pharmaceuticals Inc logo

Kala Pharmaceuticals Inc

About

Kala Pharmaceuticals Inc (NASDAQ:KALA) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 21 2026
Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine
Apr 1 2026
Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities
Mar 30 2026
KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live
Mar 18 2026
Red Light Holland Engages Kala Bio’s Researgency.AI Platform to Support Clinical Development of Filament’s Patented PEX010 Botanical Psilocybin Drug Candidate
Mar 18 2026
Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate

Financials

Revenue
$0
Market Cap
$155.11 M
EPS
-5.64

Community Chat

Ask AI

6ix6ix